Peripheral artery disease (PAD) is one of the most common vascular disorders, affecting millions of people worldwide. The condition occurs when narrowed or blocked arteries reduce blood flow to the limbs, particularly the legs, leading to pain, reduced mobility, and an increased risk of cardiovascular complications. Growing awareness of early diagnosis and advancements in minimally invasive vascular interventions are driving demand for peripheral artery disease treatment, the angioplasty devices market, and the vascular stents market. These factors are significantly contributing to the expansion of the Peripheral Artery Disease Market.

The global peripheral artery disease market was valued at USD 5.11 billion in 2024 and is expected to grow at a CAGR of 7.5% from 2025 to 2034. The market is projected to reach USD 5.49 billion in 2025 and rise to USD 10.53 billion by 2034.

Rising Demand for Peripheral Artery Disease Treatment

The demand for peripheral artery disease treatment continues to increase as healthcare providers focus on preventing serious complications such as limb ischemia, tissue damage, and amputation. Early diagnosis and timely intervention are essential for improving long-term patient outcomes.

Treatment options for PAD include:

• Lifestyle modifications
• Antiplatelet and cholesterol-lowering medications
• Supervised exercise therapy
• Balloon angioplasty
• Stent implantation
• Atherectomy procedures
• Surgical bypass in advanced cases

Minimally invasive endovascular procedures have become the preferred treatment approach for many patients because they offer reduced procedural risks, shorter hospital stays, and faster recovery compared to traditional surgery.

Growing awareness campaigns and improved diagnostic imaging are enabling earlier detection of PAD, allowing physicians to initiate treatment before severe complications develop.

Angioplasty Devices Market Supporting Minimally Invasive Care

The angioplasty devices market plays a central role in modern peripheral vascular interventions. Angioplasty procedures use balloon catheters to widen narrowed or blocked arteries and restore normal blood flow.

Common angioplasty devices include:

• Balloon catheters
• Drug-coated balloons
• Guidewires
• Inflation devices
• Crossing catheters

Drug-coated balloons have gained considerable attention because they deliver antiproliferative medications directly to the arterial wall, helping reduce restenosis after treatment.

Continuous technological advancements have improved balloon flexibility, lesion-crossing capability, and procedural precision, allowing physicians to treat increasingly complex peripheral artery lesions with greater success.

The rising preference for minimally invasive interventions continues to accelerate demand across the angioplasty devices market.

Vascular Stents Market Expanding Treatment Options

The vascular stents market has experienced significant growth as stent technology continues to evolve. Stents are small mesh-like tubes implanted inside narrowed arteries to maintain blood flow following angioplasty.

Major stent categories include:

• Bare-metal stents
• Drug-eluting stents
• Self-expanding stents
• Balloon-expandable stents
• Covered stents

Drug-eluting stents have become increasingly popular because they reduce scar tissue formation and lower the risk of restenosis. Self-expanding stents are commonly used in peripheral arteries due to their flexibility and ability to withstand vessel movement.

Advancements in stent design, biocompatible materials, and drug-delivery technologies continue to improve long-term clinical outcomes for patients undergoing peripheral vascular procedures.

Growth Drivers of the Peripheral Artery Disease Market

Several factors are fueling the expansion of the Peripheral Artery Disease Market.

Increasing Prevalence of Diabetes and Obesity

Diabetes and obesity significantly increase the risk of developing peripheral artery disease, driving demand for diagnostic and treatment solutions.

Aging Population

Older adults are more susceptible to atherosclerosis and vascular disorders, increasing the need for PAD treatment.

Rising Adoption of Minimally Invasive Procedures

Patients and healthcare providers increasingly prefer endovascular interventions because they offer faster recovery and fewer complications than open surgery.

Technological Advancements

Innovations in imaging systems, angioplasty balloons, vascular stents, and catheter technologies continue to improve procedural success rates.

Growing Awareness and Early Diagnosis

Improved screening programs and greater public awareness are enabling earlier detection and treatment of peripheral artery disease.

Market Segmentation Overview

The Peripheral Artery Disease Market can be segmented based on treatment type, disease severity, and end user.

By Treatment Type

• Medications
• Angioplasty
• Stent placement
• Atherectomy
• Surgical bypass

By End User

• Hospitals
• Specialty cardiovascular centers
• Ambulatory surgical centers

Among these, angioplasty and stent implantation account for a significant share due to the increasing preference for minimally invasive vascular interventions.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market

Key Players

• Abbott
• AngioDynamics
• B. Braun SE
• Bayer AG
• BD
• Biotronik
• Boston Scientific Corporation
• Cardinal Health
• Endologix LLC
• iVascular
• Johnson & Johnson
• Koninklijke Philips N.V.
• Medtronic
• Terumo Corporation

Regional Analysis

North America holds the largest share of the Peripheral Artery Disease Market, supported by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, favorable reimbursement policies, and widespread adoption of innovative vascular technologies.

Europe also represents a substantial market due to its aging population and strong emphasis on preventive cardiovascular care. Meanwhile, Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by increasing healthcare investments, improving access to vascular treatments, and the rising incidence of diabetes and hypertension.

Future Outlook

The future of peripheral artery disease treatment, the angioplasty devices market, and the vascular stents market will be shaped by continued innovation in endovascular technologies. Emerging developments such as drug-coated devices, bioresorbable vascular scaffolds, AI-assisted imaging, robotic-assisted interventions, and advanced catheter navigation systems are expected to improve treatment precision and patient outcomes.

As healthcare systems continue to prioritize early diagnosis, minimally invasive therapies, and personalized cardiovascular care, the Peripheral Artery Disease Market is expected to experience sustained long-term growth. Increasing investments in vascular research, medical device innovation, and preventive healthcare will further strengthen the market, offering patients safer, more effective, and less invasive treatment options for managing peripheral artery disease.

More Trending Latest Reports By Polaris Market Research:

Liver Disease Diagnostics Market

Cystatin C Assay Market

LATAM Gaucher Disease Treatment Market

Optical Coherence Tomography (Oct) Market

Cancer Gene Therapy Market

Biomaterial Wound Dressing Market

Breast Conserving Surgery Market

U.S. Plasmid Purification Market